Seasonal affective disorder (SAD) is a type of depression that occurs during a certain season of the year. This disorder is related to fluctuation in seasons; especially occurs in winter, but some people could have it during summer.
Seasonal Affective Disorder (SAD) Market: Introduction
- Seasonal affective disorder (SAD) is a type of depression that occurs during a certain season of the year. This disorder is related to fluctuation in seasons; especially occurs in winter, but some people could have it during summer. Seasonal affective disorder is most prevalent in women, people between the ages of 15 to 55, and people who live far from the equator where winter daylight hours are too short. Common symptoms of SAD are hopelessness, increased appetite, weight gain, loss of ability to concentrate, and social withdrawal, among others. Risk factors associated with this disorder are depressive disorders such as bipolar II disorder, bipolar I disorder, and others.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82931
- The global seasonal affective disorder (SAD) market can be segmented based on type, end-user, treatment, test type, and region. In terms of type, the global market can be classified into fall & winter, spring & summer, and others. Based on test type, the global seasonal affective disorder market can be categorized into psychological evaluation, lab tests, and others. The lab tests segment can be split into thyroid blood test, CBC, and others. The psychological evaluation segment can be segregated into personality tests, intelligence tests, attitude tests, achievement tests, neuropsychological tests, aptitude tests, vocational tests, direct observation tests, and others. In terms of treatment, the global seasonal affective disorder market can be divided into light therapy, psychotherapy, medications, counselling, and others. The medications segment can be bifurcated into antidepressants and others. The antidepressants sub-segment can be split into reuptake inhibitors (SSRIs) and others. The psychotherapy segment can be categorized into attachment-based psychotherapy, art therapy, behavioral therapy, cognitive analytical therapy (CAT), body psychotherapy, existential psychotherapy, gestalt therapy, and others. Based on end-user, the global market can be divided into clinics, hospitals, research institutes, and others.
Request for Analysis of COVID-19 Impact on Seasonal Affective Disorder (SAD) Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82931
Key Drivers, Restraints, and Opportunities of Global Seasonal Affective Disorder (SAD) Market
- A range of drugs and devices for treatment of seasonal affective disorder treatment are available in the market. Light therapy is utilized as the first line of therapy for seasonal affective disorder. Devices including light boxes, dawn stimulators, desk lamps, and sun visors are available in the market as light therapy for seasonal affective disorder.
- Both branded and generic drugs for seasonal affective disorder treatment are available in developed and emerging economies. Citalopram and Buproban are the most commonly used drugs for seasonal affective disorder. A number of generic options for Citalopram and Buproban are also available in the market. Therefore, easy availability of seasonal affective disorder therapeutics is projected to drive the global market.
- Experts have indicated that improper seasonal affective disorder therapeutics could have severe side effects. Dosage should be reduced in order to prevent these side effects. Adjunctive light therapy should begin with a dose titration of 7,000 lux, 4000 K blue enriched broad-spectrum white light for 15 minutes per day at midday around 2.30 pm. Then 15 minutes should be added each week until the dosage reaches a range of 45 minutes to 60 minutes per day. Average time to response and remission varies between four and six weeks. Continuous patient-physician engagement leads to better seasonal affective disorder treatment outcomes.
Pre book Seasonal Affective Disorder (SAD) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=82931<ype=S
North America to Capture Major Share of Global Seasonal Affective Disorder (SAD) Market
- North America is projected to dominate the global market in terms of share during the forecast period owing to rise in prevalence of seasonal depression. Around 5% of the population of the U.S. suffers from seasonal affective disorder. This is attributed to changing lifestyles and increase in awareness about seasonal depression and its treatment.
- Asia Pacific has less prevalence of seasonal affective disorder. Rise in awareness, increase in the geriatric population, and surge in medical tourism in emerging economies such as China and India are expected to boost the growth of the market in the region.
Read Report Overview:
Top of Form
https://www.transparencymarketresearch.com/seasonal-affective-disorder-sad-market.html
Key Players Operating in Global Seasonal Affective Disorder (SAD) Market
The global seasonal affective disorder (SAD) market is highly fragmented due to the presence of large number of key players. These players hold a major share in their respective regions. Leading players operating in the global seasonal affective disorder (SAD) market are:
- Allergan plc
- Eli Lily Company
- GlaxoSmithKline plc
- Pfizer, Inc.
- Teva Pharmaceuticals, Inc.
- Bausch Health Companies, Inc.
- F. Hoffmann-La Roche AG
- Mylan N.V.
- Sanofi AG
- Novartis AG
- Janssen Pharmaceuticals, Inc.
- The Sunbox Company
- Verilux, Inc.
- Carex Health
- Northern Light Technologies
- Beurer GmbH
- Koninklijke Philips N.V.
- Others
Browse more Market Reports:
Collagen and HA-based Biomaterials Market:
With animal-derived constituents progressively becoming a part of healthcare, especially in the case of collagen sources, religious and cultural beliefs are increasingly hampering the acceptance and adoption of collagen and hyaluronic acid-based biomaterials. Pigs and cows are a rich source of collagen, and the usage of products derived from these sources is problematic in different regional markets, as such, negatively impacting the growth of the global collagen and HA-based biomaterials market.
Neurostimulation Devices Market:
The trend of implantable neurostimulation technologies is driving the growth of the neurostimulation devices market. Companies are exploring untapped opportunities in the development of new lead interfaces in external pulse generators. Innovations in new lead interfaces are overcoming the drawbacks of conventional lead interface designs. Clinical challenges associated with traditional lead interface designs are triggering the demand for new lead interfaces.
Antimicrobial Susceptibility Test Market:
Antimicrobial resistance mechanism are emerging and spreading at a global front, which enables the ways to treat common infectious diseases thus results prolonged illness, disability and at times fatal. Antimicrobial resistance is a complex situation affecting individuals of all ages and races
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453